Articles with public access mandates - Amanda PaulovichLearn more
Not available anywhere: 2
Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation
E Marcon, H Jain, A Bhattacharya, H Guo, S Phanse, S Pu, G Byram, ...
Nature methods 12 (8), 725-731, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
CDK5–cyclin B1 regulates mitotic fidelity
XF Zheng, A Sarkar, H Lotana, A Syed, H Nguyen, RG Ivey, JJ Kennedy, ...
Nature, 1-9, 2024
Mandates: Polish National Agency for Academic Exchange
Available somewhere: 104
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
Mandates: US Department of Energy, US National Institutes of Health, Swedish Research …
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
TA Addona, SE Abbatiello, B Schilling, SJ Skates, DR Mani, DM Bunk, ...
Nature biotechnology 27 (7), 633-641, 2009
Mandates: US National Institutes of Health
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
Mandates: US Department of Energy, US National Institutes of Health
Repeatability and reproducibility in proteomic identifications by liquid chromatography− tandem mass spectrometry
DL Tabb, L Vega-Montoto, PA Rudnick, AM Variyath, AJL Ham, DM Bunk, ...
Journal of proteome research 9 (2), 761-776, 2010
Mandates: US National Institutes of Health
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
Mandates: US Department of Energy, US National Institutes of Health
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
Mandates: US National Institutes of Health
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
Mandates: US National Institutes of Health
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
Mandates: US National Institutes of Health
Proteogenomic and metabolomic characterization of human glioblastoma
LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ...
Cancer cell 39 (4), 509-528. e20, 2021
Mandates: US Department of Energy, US National Institutes of Health
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
AI Salter, RG Ivey, JJ Kennedy, V Voillet, A Rajan, EJ Alderman, ...
Science signaling 11 (544), eaat6753, 2018
Mandates: US National Institutes of Health
A targeted proteomics–based pipeline for verification of biomarkers in plasma
JR Whiteaker, C Lin, J Kennedy, L Hou, M Trute, I Sokal, P Yan, ...
Nature biotechnology 29 (7), 625-634, 2011
Mandates: US National Institutes of Health
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels
P Mertins, F Yang, T Liu, DR Mani, VA Petyuk, MA Gillette, KR Clauser, ...
Molecular & cellular proteomics 13 (7), 1690-1704, 2014
Mandates: US National Institutes of Health, Susan G. Komen
An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein …
JR Whiteaker, L Zhao, L Anderson, AG Paulovich
Molecular & Cellular Proteomics 9 (1), 184-196, 2010
Mandates: US National Institutes of Health
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
Mandates: US Department of Energy, US National Institutes of Health
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ...
Cell 183 (5), 1436-1456. e31, 2020
Mandates: US National Institutes of Health, Cancer Prevention Research Institute of …
Proteogenomic characterization of pancreatic ductal adenocarcinoma
L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ...
Cell 184 (19), 5031-5052. e26, 2021
Mandates: US National Institutes of Health
Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium
MJ Ellis, M Gillette, SA Carr, AG Paulovich, RD Smith, KK Rodland, ...
Cancer discovery 3 (10), 1108-1112, 2013
Mandates: US National Institutes of Health
Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry
B MacLean, DM Tomazela, SE Abbatiello, S Zhang, JR Whiteaker, ...
Analytical chemistry 82 (24), 10116-10124, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program